<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02717273</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-HSR#14971</org_study_id>
    <secondary_id>T32AI078875</secondary_id>
    <nct_id>NCT02717273</nct_id>
  </id_info>
  <brief_title>Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics</brief_title>
  <official_title>A Randomized, Prospective Study of Surgical Site Infections in Liver Transplant Patients Receiving Three Days of Peri-operative Antibiotic Prophylaxis Versus Intra-operative Antibiotics Only</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be to prospectively determine differences in Surgical Site Infection (SSI) if
      a prolonged course of post-operative antibiotics are used following liver transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be to prospectively determine differences in SSI if a prolonged course of
      post-operative antibiotics are used following liver transplantation. All adult patients,
      admitted to the University of Virginia (UVA) Medical Center for first-time liver
      transplantation will be randomized to the standard of care of peri-operative antibiotics or
      extended course of three total days.

      Patients will be evaluated primarily for the presence of post-operative surgical site
      infections but also for fever, elevated white blood counts, secondary infections (urinary
      tract, pneumonia, and blood stream), length of hospital stay, graft loss, and mortality for
      30 days after liver transplant.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects With Development of Surgical Site Infections</measure>
    <time_frame>within 30 days from surgery</time_frame>
    <description>development of surgical site infection, including superficial and deep incisional and organ space surgical site infections</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Post-operative Fever</measure>
    <time_frame>24 hours from surgery</time_frame>
    <description>fever above 38.5 degrees Celsius 24 hours after the end of the liver transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Elevated White Blood Count (WBC)</measure>
    <time_frame>24 hours from surgery</time_frame>
    <description>above 15,000 within 24hours after the end of the liver transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Nosocomial Infection</measure>
    <time_frame>within 30 days from surgery</time_frame>
    <description>diagnosis of any new infection other than an SSI within 30 days from surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>within 30 days from surgery</time_frame>
    <description>days hospitalized after liver transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Graft Loss</measure>
    <time_frame>within 30 days from surgery</time_frame>
    <description>complete loss of liver function in recipient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Mortality</measure>
    <time_frame>within 30 days from surgery</time_frame>
    <description>death within 30 days of liver transplant</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Liver Transplantation</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>standard peri-operative antibiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>extended three-day course of antibiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard</intervention_name>
    <description>peri-operative antibiotic regimen only</description>
    <arm_group_label>standard peri-operative antibiotics</arm_group_label>
    <other_name>Peri-operative only antibiotics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>extended</intervention_name>
    <description>extended three-day course of antibiotics</description>
    <arm_group_label>extended three-day course of antibiotics</arm_group_label>
    <other_name>Extended, three-day antibiotics</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>liver transplant</intervention_name>
    <description>orthotopic liver transplantation</description>
    <arm_group_label>extended three-day course of antibiotics</arm_group_label>
    <arm_group_label>standard peri-operative antibiotics</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients ≥ 18 years of age.

          -  Eligible for liver transplantation by UVA standard protocol.

          -  First-time transplantation.

          -  No active infections - requiring antibiotics - excluding antifungals.

        Exclusion Criteria:

          -  All patients &lt; 18 years of age.

          -  Previous liver transplantation.

          -  Active infections - requiring antibiotics.

          -  Allergy to all standard peri-operative antibiotics (piperacillin/tazobactam or UVA
             standard alternatives for Penicillin allergic patients: ciprofloxacin and vancomycin).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert G Sawyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UVA</affiliation>
  </overall_official>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2016</study_first_posted>
  <results_first_submitted>May 18, 2018</results_first_submitted>
  <results_first_submitted_qc>June 18, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 17, 2018</results_first_posted>
  <last_update_submitted>June 18, 2018</last_update_submitted>
  <last_update_submitted_qc>June 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Robert Sawyer, MD</investigator_full_name>
    <investigator_title>Profesor of Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Peri-operative Antibiotic Regimen</title>
          <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
        </group>
        <group group_id="P2">
          <title>Extended Three-day Course of Antibiotics</title>
          <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Peri-operative Antibiotic Regimen</title>
          <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
        </group>
        <group group_id="B2">
          <title>Extended Three-day Course of Antibiotics</title>
          <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" lower_limit="51" upper_limit="58"/>
                    <measurement group_id="B2" value="58.5" lower_limit="55" upper_limit="61"/>
                    <measurement group_id="B3" value="57.5" lower_limit="52" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Development of Surgical Site Infections</title>
        <description>development of surgical site infection, including superficial and deep incisional and organ space surgical site infections</description>
        <time_frame>within 30 days from surgery</time_frame>
        <population>Had liver transplant</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Peri-operative Antibiotic Regimen</title>
            <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
          <group group_id="O2">
            <title>Extended Three-day Course of Antibiotics</title>
            <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Development of Surgical Site Infections</title>
          <description>development of surgical site infection, including superficial and deep incisional and organ space surgical site infections</description>
          <population>Had liver transplant</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Post-operative Fever</title>
        <description>fever above 38.5 degrees Celsius 24 hours after the end of the liver transplant</description>
        <time_frame>24 hours from surgery</time_frame>
        <population>Had liver transplant</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Peri-operative Antibiotic Regimen</title>
            <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
          <group group_id="O2">
            <title>Extended Three-day Course of Antibiotics</title>
            <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Post-operative Fever</title>
          <description>fever above 38.5 degrees Celsius 24 hours after the end of the liver transplant</description>
          <population>Had liver transplant</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Elevated White Blood Count (WBC)</title>
        <description>above 15,000 within 24hours after the end of the liver transplant</description>
        <time_frame>24 hours from surgery</time_frame>
        <population>Had liver transplant</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Peri-operative Antibiotic Regimen</title>
            <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
          <group group_id="O2">
            <title>Extended Three-day Course of Antibiotics</title>
            <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Elevated White Blood Count (WBC)</title>
          <description>above 15,000 within 24hours after the end of the liver transplant</description>
          <population>Had liver transplant</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Nosocomial Infection</title>
        <description>diagnosis of any new infection other than an SSI within 30 days from surgery</description>
        <time_frame>within 30 days from surgery</time_frame>
        <population>Had liver transplant</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Peri-operative Antibiotic Regimen</title>
            <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
          <group group_id="O2">
            <title>Extended Three-day Course of Antibiotics</title>
            <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Nosocomial Infection</title>
          <description>diagnosis of any new infection other than an SSI within 30 days from surgery</description>
          <population>Had liver transplant</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>days hospitalized after liver transplant</description>
        <time_frame>within 30 days from surgery</time_frame>
        <population>Had liver transplant</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Peri-operative Antibiotic Regimen</title>
            <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
          <group group_id="O2">
            <title>Extended Three-day Course of Antibiotics</title>
            <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>days hospitalized after liver transplant</description>
          <population>Had liver transplant</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" lower_limit="6.5" upper_limit="11"/>
                    <measurement group_id="O2" value="7.5" lower_limit="6" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Graft Loss</title>
        <description>complete loss of liver function in recipient</description>
        <time_frame>within 30 days from surgery</time_frame>
        <population>Had liver transplant</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Peri-operative Antibiotic Regimen</title>
            <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
          <group group_id="O2">
            <title>Extended Three-day Course of Antibiotics</title>
            <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Graft Loss</title>
          <description>complete loss of liver function in recipient</description>
          <population>Had liver transplant</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Mortality</title>
        <description>death within 30 days of liver transplant</description>
        <time_frame>within 30 days from surgery</time_frame>
        <population>Had liver transplant</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Peri-operative Antibiotic Regimen</title>
            <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
          <group group_id="O2">
            <title>Extended Three-day Course of Antibiotics</title>
            <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Mortality</title>
          <description>death within 30 days of liver transplant</description>
          <population>Had liver transplant</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Standard Peri-operative Antibiotic Regimen</title>
          <description>The standard of care at the University of Virginia Medical Center for liver transplantation patients is a 3.375 gram dose of piperacillin / tazobactam (Zosyn®) at the time of induction of anesthesia, though this dose may be adjusted for renal insufficiency. This dose is repeated during the operation every six hours.
standard: peri-operative antibiotic regimen only
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
        </group>
        <group group_id="E2">
          <title>Extended Three-day Course of Antibiotics</title>
          <description>For those patients randomized to the study group, antibiotics will be started as per the usual intra-operative dosing regimen, then continued to provide coverage for 72 hours.
This is typically provided as additional doses of 3.375 grams of piperacillin / tazobactam (Zosyn®) every 8 hours for 3 total days (giving a total of 72 hours of antibiotic coverage), though this may be altered based on kidney function.
extended: extended three-day course of antibiotics
steroids: 500mg methylprednisolone intravenously
liver transplant: orthotopic liver transplantation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert Sawyer</name_or_title>
      <organization>University of Virginia</organization>
      <phone>4349821632</phone>
      <email>rws2k@virginia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

